Evcarco, Inc. (OTC:EVCA)
EVCA is pleased to present to the shareholders of EVCA the latest update from its Italian manufacturer TAZZARI.
Over 6 months have passed since ZERO was launched. While a discerning public admires its technological features, ecological concept, its design and the performance of this all-electric vehicle built using cutting-edge techniques, the TAZZARI team is busy planning and defining the vehicle's coming innovations.
Planned for spring next year there will be a number of innovations that are currently at an advanced stage of development.
These include a driver control panel with touch-screen technology. Part of the dashboard, the new control panel will give the driver easy, finger-tip control over a range of vehicle functions. Its design is essential and ultra-modern and this instrument represents a major innovation in the automotive sector, bringing it closer to that of latest-generation communication devices such as the iPod.
Externally, there will be a number of new optional features such as LED lights and front fog lamps. As far as drivability is concerned, adjustable suspensions are being developed to suit all road types, from urban freeways to off-road surfaces. Further developments for ZERO remain top-secret for the time being, but will be disclosed at the end of the year and will be available in 2011.
Spring 2012 will see the Roadster take to the roads.
Just 18 months before we will see the open top version of the TAZZARI ZERO ready for those star-filled summer nights. Available in Spring 2012, the TAZZARI ZERO Roadster is perfect for the free-spirited lovers of driving sensations.
Scott O'Neal, COO of EVCA, stated, "As EVCARCO moves forward to find forward thinking, Future Driven®, dealers in the U.S. & South America we are excited to be working with TAZZARI as they develop new products, improve advanced technology & performance. We feel that working with an Italian manufacturer with executive styling & sustainable technology will make our future not only greener, but the envy of the road."
EVCA is a development stage company and engages in selling environmentally conscious automobiles in the United States. EVCA offers electric vehicles and pre-owned vehicles converted to various green technologies; and financing, warranties, maintenance, and mechanical services. EVCA was incorporated in 2008 and is based in Fort Worth, Texas.
To learn more about EVCA visit: http://www.evcarco.com
Proteonomix, Inc. (OTCPK:PROT)
PROT, a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, announced further developments with its Joint Venture Company, XGEN Medical LLC ("XGen") towards implementing operations in the United Arab Emirates (U.A.E.).
PROT is the majority shareholder in XGen with the balance held by an anonymous investor group. PROT personnel were on the ground in the U.A.E. over the past weeks to work together with the Investor Group through the start up phase. To date, XGen has established an office in the Monarch Office Tower on the prestigious Sheikh Zayed Road, and a residence for visiting PROT personnel on Jumeira 2.
PROT, a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products. The stem cell therapy involves the introduction of healthy new stem cells to repair and replace damaged or lost cells. It offers product for the treatment of anti-aging and damaged skin. PROT develops cosmetic products using its technologies, Secreted Matrix and Matrix NC-138 that is a stem cell derived proteins technology. PROT is also involved in the operation of retail Web site, Proteoderm.com to sell its anti-aging line of skin care products; develops therapeutic modalities for the treatment of cardiovascular disease; and engages in the reproductive tissue banking, including sperm, ova, ovarian tissue, and testicular tissue. In addition, PROT develops intellectual properties for patent applications, including a medium and scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a cord blood banking cryopreservation bag, and a device to eliminate malformed stem cells via filtration. Further, PROT is developing pre-clinical-stage therapeutic agents and treatments for cancer, diabetes, heart, lung, and kidney diseases, as well as for stem cell bone marrow and organ transplants. PROT was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. PROT was founded in 2005 and is based in Mountainside, New Jersey.
To learn more about PROT visit: http://www.proteonomix.com
Shenandoah Telecommunications Company (Nasdaq:SHEN)
SHEN announces financial and operating results for the three months ended June 30, 2010.
Second Quarter 2010 Highlights:
- Revenue of $42.3 million, an increase of 5.3% from second quarter 2009
- Net income from continuing operations of $4.5 million, roughly equivalent to second quarter of 2009, after excluding $3.8 million ($2.3 million after-tax) in costs related to closing and curtailing certain pension plans
- Adjusted operating income before depreciation and amortization (adjusted OIBDA) of $20.3 million, an increase of $0.4 million from the second quarter of 2009
- Completed the distribution of pension benefits with a final cash contribution to the defined benefit pension plan of $1.0 million
SHEN, through its subsidiaries, provides regulated and unregulated telecommunications services to end-user customers and other communications providers in the southeastern United States. SHEN was founded in 1902 and is headquartered in Edinburg, Virginia.
To learn more about SHEN visit: http://www.shentel.com
ShengdaTech, Inc. (Nasdaq:SDTH)
SDTH, a leading manufacturer of nano-precipitated calcium carbonate ("NPCC") in China, today reported its unaudited financial results for the three months and six months ended June 30, 2010.
Net revenues from continuing operations in the second quarter of 2010 increased by 27.7% to $33.2 million from $26.0 million in the second quarter of 2009. The net revenue increase is a result of expanded production capacity to meet the growing market demand as well as an increase in average selling price.
SDTH engages in manufacturing, marketing, and selling NPCC products in China. SDTH converts limestone into NPCC using its proprietary technology co-developed with Tsinghua University. SDTH sells its products through a direct sales force. SDTH serves customers in the tire, polyvinyl chloride building materials, ink, paint, latex, adhesive, paper, and polyethylene industries. SDTH also exports its products to Singapore, Thailand, South Korea, Malaysia, India, and Israel. SDTH was founded in 2005 and is based in Shanghai, China.
To learn more about SDTH visit: http://www.shengdatechinc.com
Shengkai Innovations, Inc. (Nasdaq:VALV)
VALV, a leading ceramic valve manufacturer in the People's Republic of China, recently announced that it has celebrated the launch of its new production facility, in Tianjin.
VALV has completed the construction of new manufacturing facility and commenced trial production. After completing installation of equipment and machines, and trial production, VALV has commenced commercial production this week. VALV plans to quickly ramp up production and reach full utilization rate of a designed annual production of 24,000 units of ceramic valves by December 2010, which will more than triple the prior manufacturing facility's designed capacity of 7,500 units.
VALV, through its subsidiaries, designs, manufactures, and sells ceramic valves; and manufactures and sells ceramic materials. VALV is based in Tianjin, the People's Republic of China.
To learn more about VALV visit: http://www.shengkaiinnovations.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received fifteen thousand dollars in cash and thirty-five thousand dollars in EVCARCO, Inc. (OTC:EVCA) restricted shares for 30 days of advertising. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (OTCPK:PROT)